Skip to main content

AD: Shocked! The peak value of plasma Aβ42/Aβ40 began to decline 41 years before the deposition of brain Aβ!

 AD: Shocked! The peak value of plasma Aβ42/Aβ40 began to decline 41 years before the deposition of brain Aβ! Alzheimer's diseases: New discovery on plasma Aβ42/Aβ40.  AD: Shocked! The peak value of plasma Aβ42/Aβ40 began to decline 41 years before the deposition of brain Aβ! Amyloid β (Aβ) plaque deposition and phosphorylated tau (p-tau) protein tangles are two important pathological features of Alzheimer's disease (AD), and there are many kinds of AD biomarkers derived around them, Knowledge of the longitudinal trajectories of key markers could not only help improve the selection and monitoring of participants in clinical trials, but also help identify those at high risk for neurodegenerative changes and cognitive impairment.   Although research on AD biomarkers has increased substantially in recent years, research on longitudinal changes in biomarkers is relatively limited. Studies have shown that the levels of plasma Aβ 42 /Aβ 40 , p-tau181 and glial fibrillary acidic...

"Starve cancer cells" may become a reality!

"Starve cancer cells" may become a reality!


"Starve cancer cells" may become a reality! But how hungry is beyond your imagination


In recent years, we will often see many articles about how to starve cancer cells, but in fact, these studies basically start with cutting off sugar intake, but is this really the case?


In recent years, we will often see many articles about how to starve cancer cells, but in fact, these studies basically start with cutting off sugar intake, but is this really the case? A recent subversive study published in the journal Nature makes "starve cancer cells" a feasible reality, but the energy source to be cut off is not what people think.



Image source: "Nature" official website


The main source of energy for the human body comes from carbohydrates (sugars), fats and proteins. Generally speaking, sugars are the preferred energy source. Past studies have also confirmed that cancer cells seem to love sugar more and consume more. carbohydrate. 


An article published by Otto Warburg in 1922 showed that cancer tissues consume glucose at a very high rate. Based on this, some people have proposed the treatment of "starve cancer cells"-reducing energy intake, such as reducing sugars. Ingestion thus inhibits the growth of cancer cells.



But this very disruptive research-that is, the above article has overturned the cancer metabolism model that has been continuously developed and improved for nearly 100 years. This latest study found that in the tumor microenvironment, it is not cancer cells that consume the most glucose!



In the process of glucose metabolism in tumors, PET imaging technology is now commonly used to image the basic structure of the tumor, and then the glucose is labeled with a radioactive tracer (FDG) to show the glucose metabolism process in the tumor microenvironment. But FDG-PET imaging technology does not always achieve the goals that people expect. For this reason, researchers have found nutritive glutamine, which has been found to be a common "ration" for cancer cells in recent years.



Many previous studies have actually confirmed that because cancer cells invade very quickly, many cancer cells do not rely on glucose to supply energy. One of their favorite "rations" is Glutamine-this love The degree will even exceed that of glucose, which means to "starve cancer cells", and it is more practical to cut off the binding of glutamine.




So the researchers began further research and tracking. This operation is not very difficult in concept. Simply put, two different tracers were used for tumor mice, one for tracking glucose and the other for tracking valleys. Aminoamide-when nutrients enter the tumor microenvironment, the tumor is separated, and then cell surface proteins and flow cytometry are used to classify the cells-the cells are distinguished by cell surface proteins, which are normal cells and tumor cells It is also an immune cell, and the emission of the cell is measured to determine what kind of nutrients the cell has absorbed.




However, the results of the experiment were beyond the expectations of the researchers: when analyzing six common tumor models including kidney cancer, breast cancer, colorectal cancer, etc., it was found that the macrophages that absorbed the most glucose in the tumor tissues ! Then there are T cells, and then cancer cells. Correspondingly, cancer cells absorb the most glutamine!



The researchers said that the cancer types involved in this study are very common, and perhaps this is a common phenomenon in tumors-and this discovery is in sharp contrast with the current metabolic model in the tumor microenvironment, which means The previous idea that cancer cells suppress immune cells by consuming glucose may be wrong.




In fact, in order to cope with uncertainty and improve their own adaptability, cancer cells may have been looking for differentiated metabolic patterns from the beginning, including a preference for absorbing glutamine and fatty acids to maintain their own energy supply.




This study points us to another path. Since cancer cells use glutamine for energy supply, blocking this path may reduce the occurrence of tumors. In fact, other research teams have discovered the corresponding pathway that can cut off the absorption of glutamine and inhibit tumor growth.



In March of this year, an article published by the Prebis Institute of Medical Discovery in the AACR Association's "Molecular Cancer Therapeutics" magazine found a substance that can cut off the path for cancer cells to transport glutamine. Researchers found the best blocking substance among 7,000 different compounds, and conducted related experiments, and found that it can block the development of a variety of tumors and inhibit their growth, which means "starving to death" at the molecular level. Cancer cells are possible.




But "starving cancer cells" does not rely on reducing the intake of foods such as starch. On the contrary, perhaps in order for immune cells to work harder, we can supply immune cells with more glucose. In fact, the articles we often read are that cancer patients cannot eat this or that, and weight loss has become the impression of many cancer patients.




We can "starve cancer cells" from the molecular level instead of intercepting them from the food level. It is not advisable not to eat staple foods or high-calorie foods. At the same time, we have also seen that immune cells rely on glucose to supplement energy. , So adequate nutrition is an important weapon to ensure that we fight cancer.





Popular posts from this blog

After 70 years of age, language ability declines significantly, and more play and activity can delay it!

After 70 years of age, language ability declines significantly, and more play and activity can delay it!  70~74 years old is a turning point in the decline of language ability Playing more and more active can delay the decline of speech function Liu Chuqun, Professor of Jiangxi Normal University Decreased language fluency is an important speech performance of the elderly.  Studies have found that the age of 70 to 74 is an important turning point for the decline of verbal fluency, but a positive attitude and a healthy lifestyle can delay the decline of the elderly’s verbal fluency to a certain extent. After 70 years of age, language ability declines significantly Most of the elderly, especially the elderly, have these kinds of expressions: words that have no real meaning are repeated back and forth, lack of information to express, the words are inconsistent with what they think and form a verbal error, and the words cannot be remembered by the mouth (tip of tongue phenomenon), ...

European Medicines Agency investigates whether Johnson & Johnson COVID-19 vaccine is associated with thrombosis

European Medicines Agency investigates whether Johnson & Johnson COVID-19 vaccine is associated with thrombosis European Medicines Agency investigates whether Johnson & Johnson COVID-19 vaccine is associated with thrombosis. The European Medicines Agency said on the 9th that it is investigating whether the new crown vaccine developed by Johnson & Johnson Pharmaceuticals Co., Ltd. is associated with thrombosis. In the United States, four Johnson & Johnson vaccinators developed blood clots. This regulatory agency continues to investigate whether there is a causal link between the new crown vaccine developed by AstraZeneca Pharmaceuticals in the United Kingdom and the presence of blood clots in the vaccinators, and it has also found that some vaccinators have other diseases. Thrombosis associated with Johnson & Johnson vaccine? The European Medicines Agency said in a report on the 9th that four Johnson & Johnson vaccine vaccinators in the United States had severe t...

Medical news update on March 27 2022

  Medical news update on March 27 2022 Drugs News GlaxoSmithKline anti-HIV injectable drug gets the latest FDA approval!  7 mins ago GlaxoSmithKline anti-HIV injectable drug gets the latest FDA approval!   GlaxoSmithKline's anti-HIV injectable drug gets the latest FDA approval! Direct... Cancers Immunotherapy News Tumors How about patients now after CAR-T cell infusion ten years ago?  8 mins ago How about patients now after CAR-T cell infusion ten years ago?   How about patients now after CAR-T cell infusion... Cancers News Stem Cells Cell Stem Cell: Do Human Stem Cells Contain Oncogenic Mutations?  10 mins ago Cell Stem Cell: Do Human Stem Cells Contain Oncogenic Mutations?   Cell Stem Cell: Do Human Stem Cells Contain Oncogenic... COVID-19 News Simultaneous infection with COVID-19 and influenza increases the risk of severe illness and death  11 mins ago Simultaneous infection with COVID-19 and influenza increases the risk of severe illness and d...